Literature DB >> 21847319

Constipation in Parkinson's disease.

.   

Abstract

Entities:  

Year:  2011        PMID: 21847319      PMCID: PMC3152159     

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.

Introduction

Constipation is a common problem in Parkinson's disease (PD), occurring in about 50–60% of patients and may occur even before the motor symptoms appear.[1] Various mechanisms causing it are degeneration of neurons in myenteric plexus of colon with presence of Lewy bodies, weakness and incoordinated contraction of muscles of pelvic floor and abdominal muscles which is unable to straighten, anorectal angle preventing passage of stool, dystonic contractions of muscles, megacolon and volvulus.[23] Principles of management are the following. In early stages, simple measures may be tried, but later on, combinations may be needed. Dietary modifications include increased intake of fluids (6–8 glasses of water/day), high fiber diet, and plenty of raw vegetables/salads, and bran can be added to increase the bulk. Exercise should be increased. Medicines that can be helpful include milk of magnesia, Cisapride, Mosapride (5HT4 agonist/partial 5HT3 antagonist), enemas, suppositories, stool softeners such as lactulose.

Pain/Dysesthesia in PD

Pain is a common problem in PD and occurs in about 50% of patients. It occurs both in early phase and in advanced stage of disease – more often in off period, but also in on period.[45] The exact mechanism of pain and dysesthesia is not known, but several mechanisms are proposed. These are:[67] abnormal firing in afferent nerves in dystonic muscles, impaired ability of basal ganglia to modulate sensory information, alteration in serotonergic pathways, decreased activity of dopaminergic fibers on dorsal horn and intermediolateral column of spinal cord and reduced pain threshold due to dopamine deficiency by action on frontal, insular and cingulated gyrus (limbic system) and reduced nociceptive flexion reflex threshold by the same mechanism. The presentation of pain/dysesthesia includes: painful “frozen shoulder” usually on the side of first symptom, especially before treatment is started (usually early in the disease), off-period limb pain, off-period painful foot dystonia, pain and dysesthesia on chest or abdomen. Some patients may have mechanical nerve root distribution pain/paresthesia coldness/numbness, arthritis and pain due to bursitis. The management of these symptoms[8] is by introduction of dopaminergic therapy with dopamine agonist or levodopa, passive and active exercise and DBS (in advanced stages).
  8 in total

Review 1.  Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable.

Authors:  S Waseem; K Gwinn-Hardy
Journal:  Postgrad Med       Date:  2001-12       Impact factor: 3.840

Review 2.  Pineal melatonin and sensory symptoms in Parkinson disease.

Authors:  R Sandyk
Journal:  Ital J Neurol Sci       Date:  1989-08

Review 3.  Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology.

Authors:  L L Edwards; E M Quigley; R F Pfeiffer
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

Review 4.  Pain in Parkinson's disease: pathology to treatment, medication to deep brain stimulation.

Authors:  David F Drake; Steve Harkins; Abu Qutubuddin
Journal:  NeuroRehabilitation       Date:  2005       Impact factor: 2.138

5.  Oral and genital pain syndromes in Parkinson's disease.

Authors:  B Ford; E D Louis; P Greene; S Fahn
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

Review 6.  The role of the basal ganglia in nociception and pain.

Authors:  Eric H Chudler; Willie K Dong
Journal:  Pain       Date:  1995-01       Impact factor: 6.961

7.  Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.

Authors:  Robert D Abbott; G Webster Ross; Lon R White; Wayne T Sanderson; Cecil M Burchfiel; Michael Kashon; Dan S Sharp; Kamal H Masaki; J David Curb; Helen Petrovitch
Journal:  J Neurol       Date:  2003-10       Impact factor: 4.849

8.  Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation.

Authors:  C Singaram; W Ashraf; E A Gaumnitz; C Torbey; A Sengupta; R Pfeiffer; E M Quigley
Journal:  Lancet       Date:  1995-09-30       Impact factor: 79.321

  8 in total
  1 in total

1.  Successful treatment of recurrent stoma prolapse after Hartmann's procedure through ileorectal anastomosis: A case report.

Authors:  Noriya Takayama; Shingo Tsujinaka; Nao Kakizawa; Soutoku Someya; Jun Takahashi; Fumi Hasegawa; Rina Kikugawa; Yasuyuki Miyakura; Toshiki Rikiyama
Journal:  Int J Surg Case Rep       Date:  2017-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.